News

Could CAR-T Therapy Be a Cure for Lupus? Early Trials Show Promise

In lupus the CAR-T cells are modified not to target cancer, but instead a different type of immune cell called the B cell.

Novartis Pharma AG: Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2 Patients ...
Novartis1d

Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2 Patients treated ...
Forbes6d

How To Get Ozempic: Eligibility Criteria, Cost And More

Learn more about how to get Ozempic, including who can take it and where to find it, plus cost issues and the latest safety concerns to know about.